Nordson Corporation Q4 2025 Earnings Recap
Get alerts when NDSN reports next quarter
Set up alerts — freeNordson Corporation delivered solid Q4 and full-year results for fiscal 2025, with record sales, adjusted earnings growth, and strong cash flow generation, reflecting the successful execution of its Ascend Strategy.
Earnings Per Share
Beat
$3.03
vs
$2.93 est.
+3.4% surprise
Revenue
Miss
751820000
vs
761014588 est.
-1.2% surprise
Market Reaction
1-Day
+0.99%
5-Day
+2.09%
30-Day
+15.49%
See NDSN alongside your other holdings
Add to your portfolio — freeKey Takeaways
- Q4 sales rose 1% YoY to $752 million, with adjusted EPS up 9% to $3.03, exceeding guidance.
- Record EBITDA of $256 million and an EBITDA margin of 34% demonstrate strong operational efficiency amid market challenges.
- Free cash flow conversion reached 136% of net income, supporting $300 million in share repurchases and dividend increases for the 62nd consecutive year.
- The divestiture of the medical contract manufacturing business improved margins and enhanced focus on strategic medical segments.
This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit
NDSN on AllInvestView.
Also Reported on December 12, 2025
Get the Full Picture on NDSN
Track Nordson Corporation in your portfolio with real-time analytics, dividend tracking, and more.
View NDSN Analysis